ArticleAnalytical and bioanalytical chemistry2026
Sub-3 μm porous graphitic carbon for highly polar metabolomics: orthogonal selectivity and comparison with HILIC and reversed-phase chromatography.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The analysis of the polar metabolome remains a major challenge in LC-MS. Beyond established hydrophilic interaction liquid chromatography (HILIC) and reversed-phase (RP) workflows, alternative and orthogonal chromatographic approaches are required to improve the detection and quantification of compounds with low logP values and structurally related isomers. In this study, we evaluated the performance of sub-3 µm porous graphitic carbon (PGC) stationary phase and benchmarked it against state-of-the-art HILIC and RP approaches. Flow rate, column temperature, organic modifier, mobile-phase composition, and pH were optimized using a representative panel of highly polar endogenous metabolites. The three chromatographic modes exhibited markedly complementary selectivity profiles. HILIC provided the broadest coverage of nucleotides and related metabolites, whereas PGC showed enhanced performance for sugar phosphates, polyamines, and, particularly, tricarboxylic acid (TCA) cycle intermediates. Focused optimization for TCA cycle metabolites improved peak shape and signal-to-noise ratio and enabled the separation of citrate and isocitrate, outperforming both HILIC and reversed-phase chromatography for the detection of this metabolite class under the investigated conditions. In mouse liver extracts, PGC detected a complementary subset of metabolites not observed using HILIC or reversed-phase chromatography, confirming its distinctive selectivity in a complex biological matrix. As a proof of concept, the optimized PGC method was applied to lipopolysaccharide-stimulated macrophages using a hybrid workflow combining multiplexed parallel reaction monitoring for the absolute quantification of TCA cycle intermediates with data-dependent acquisition for global metabolic profiling. The workflow captured the characteristic metabolic reprogramming associated with macrophage inflammatory activation. Overall, sub-3 µm PGC represents a valuable orthogonal chromatographic platform for extending analytical coverage and improving the characterization of highly polar metabolites.
Indexed as
Identifiers
42825828What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.